Cannabinoids and Dementia: A Review of Clinical and Preclinical Data
Abstract The endocannabinoid system has been shown to be associated with neurodegenerative diseases and dementia. We review the preclinical and…
cannabinoids
Therapeutic Potential of Non-Psychotropic Cannabidiol in Ischemic Stroke
Abstract Cannabis contains the psychoactive component delta9-tetrahydrocannabinol (delta9-THC), and the non-psychoactive components cannabidiol (CBD), cannabinol, and cannabigerol. It is well-known…
Molecular Mechanisms Involved in the Antitumor Activity of Cannabinoids on Gliomas: Role for Oxidative Stress
Abstract Cannabinoids, the active components of Cannabis sativa, have been shown to exert antiproliferative and proapoptotic effects on a wide…
New approaches in the management of spasticity in multiple sclerosis patients: role of cannabinoids
Abstract Cannabinoids such as Cannabis-based medicinal extracts (CBMEs) are increasingly being used in the treatment of spasticity associated with multiple…
Cannabinoids in the management of spasticity associated with multiple sclerosis
Abstract The endocannabinoid system and cannabinoid-based treatments have been involved in a wide number of diseases. In particular, several studies…
Cannabinoids in the management of difficult to treat pain
Abstract This article reviews recent research on cannabinoid analgesia via the endocannabinoid system and non-receptor mechanisms, as well as randomized…